Your Partner for Process Development and cGMP Manufacturing
home > core services > purification > process development

Goodwin Biotechnology to Present at the BioProcess International Meeting 

Emphaze® AEX as the Utility Infielder of Your Downstream Toolbox

For more information on Jack Vicalvi's presentation please click here

Hyung-Il Lee, PhD
Staff Scientist
 
Dr. Lee has nearly 20 years of experience in the Biotechnology field honing his skills on protein purification and characterization technologies at Rutgers University, Icon Genetics, Altor BioScience, and The Scripps Research Institute. Over the last few years, he has focused on developing purification protocols for many clients at Goodwin Biotechnology and worked on antibody : drug conjugates for the Process Development group at the firm.  Dr. Lee earned his Master’s degree in Biochemistry at Korea University and his doctorate in Genetics from Michigan State University, and has contributed to a patent and several publications in prestigious, peer-reviewed publications.
Picture

Process Development

Goodwin Biotechnology's downstream process development group has well over 50 years of experience in developing and refining purification processes. With an extensive background in the purification of proteins from mammalian, as well as plant and animal transgenic systems, Goodwin Biotechnology can quickly develop a purification process for clients that will maximize yields for the target molecule, meet required purity levels, and be compliant with the regulatory requirements for product's development status.

Goodwin Biotechnology has a broad range of experience with the following: 
Monoclonal Antibodies, Antibody Fragments (including IgG, IgA and IgM subclasses)
  • Recombinant Proteins
  • Growth Factors, Cytokines
  • Hormones, Enzymes
  • Antibody Conjugates
  • Radio-labeled Antibodies
Goodwin Biotechnology has experience with affinity, ion exchange, hydrophobic interaction, mixed mode, MEP chromatography, and other processes. Our experience includes UF processes using TFF technologies in both flat plate and hollow fiber formats. Viral clearance techniques employed include low pH inactivation and nanofiltration. We work closely with filtration media providers to develop a filtration process that works within the confines of your process and product requirements and provides the necessary viral removal.
For more information on our Purification Process Development please fill out the form below.